KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Cost of Revenue (2016 - 2025)

LifeMD (LFMD) has disclosed Cost of Revenue for 14 consecutive years, with -$60.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 497.29% year-over-year to -$60.1 million, compared with a TTM value of $27.7 million through Dec 2025, down 6.87%, and an annual FY2025 reading of $27.7 million, up 29.26% over the prior year.
  • Cost of Revenue was -$60.1 million for Q4 2025 at LifeMD, down from $55.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $55.6 million in Q3 2025 and bottomed at -$60.1 million in Q4 2025.
  • Average Cost of Revenue over 5 years is $4.1 million, with a median of $4.6 million recorded in 2022.
  • The sharpest move saw Cost of Revenue soared 14873.56% in 2021, then tumbled 497.29% in 2025.
  • Year by year, Cost of Revenue stood at -$42.7 million in 2021, then soared by 81.53% to -$7.9 million in 2022, then skyrocketed by 48.14% to -$4.1 million in 2023, then skyrocketed by 469.89% to $15.1 million in 2024, then crashed by 497.29% to -$60.1 million in 2025.
  • Business Quant data shows Cost of Revenue for LFMD at -$60.1 million in Q4 2025, $55.6 million in Q3 2025, and $3.0 million in Q2 2025.